UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 224

Sortiert nach

Crucial steps in the natural history of inflammatory bowel disease

World journal of gastroenterology : WJG, 2012-08, Vol.18 (29), p.3790-3799

2012

Volltextzugriff (PDF)

Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease

Clinical gastroenterology and hepatology, 2011, Vol.9 (1), p.30-35

2011

Volltextzugriff (PDF)

SAPHO Syndrome in Crohn’s Disease Successfully Treated with Ustekinumab: Case Report and Review of the Literature

EMJ. Gastroenterology, 2023-11

2023

Volltextzugriff (PDF)

Comparative Effectiveness Research: A Roadmap to Sail the Seas of IBD Therapies

Journal of clinical medicine, 2022-11, Vol.11 (22), p.6717

2022

Volltextzugriff (PDF)

Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease

Digestive and liver disease, 2017-06, Vol.49 (6), p.604-617

2017

Volltextzugriff (PDF)

Stricturing Crohn's disease: what is the role of endoscopic stenting? A systematic review

Clinical endoscopy, 2023-11, Vol.56 (6), p.726-734

2023

Volltextzugriff (PDF)

Should the Mediterranean diet be recommended for inflammatory bowel diseases patients? A narrative review

Frontiers in nutrition (Lausanne), 2023-01, Vol.9, p.1088693-1088693

2023

Volltextzugriff (PDF)

Mucosal healing in inflammatory bowel disease: Treatment efficacy and predictive factors

Digestive and liver disease, 2013-12, Vol.45 (12), p.978-985

2013

Volltextzugriff (PDF)

Effectiveness of ustekinumab in patients with refractory Crohn’s disease: a multicentre real-life study in Italy

Therapeutic advances in gastroenterology, 2022-02, Vol.15, p.17562848211072412-17562848211072412

2022

Volltextzugriff (PDF)

Timing of Cholecystectomy for Acute Calculous Cholecystitis: A Meta-Analysis

The American journal of gastroenterology, 2004-01, Vol.99 (1), p.147-155

2004

Volltextzugriff (PDF)

Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus

Gastroenterology research and practice, 2019, Vol.2019, p.3108025-9

2019

Volltextzugriff (PDF)

Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study

Journal of Crohn's and colitis, 2016-08, Vol.10 (8), p.913-924

2016

Volltextzugriff (PDF)

Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life Study

Gastroenterology research and practice, 2018-01, Vol.2018, p.4195968-7

2018

Volltextzugriff (PDF)

Intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant Sars-CoV-2 infection

Digestive and liver disease, 2022-11, Vol.54 (11), p.1598-1599

2022

Volltextzugriff (PDF)

Randomized controlled trials in prevention of postsurgical recurrence in Crohn's disease

Reviews on recent clinical trials, 2012-11, Vol.7 (4), p.307

2012

Volltextzugriff (PDF)

Author's Reply: ``Use of biologics for the management of Crohn's disease'

Digestive and liver disease, 2023-07, Vol.55 (7), p.990-990

2023

Volltextzugriff (PDF)

Mucosal healing as a treatment for IBD?

Expert review of gastroenterology & hepatology, 2014-07, Vol.8 (5), p.457-459

2014

Volltextzugriff (PDF)

No impact of restructuring IBD-related activity during COVID-19 outbreak on patient outcomes. A single Center experience

Digestive and liver disease, 2021-09, Vol.53 (9), p.1076-1078

2021

Volltextzugriff (PDF)

Crohn's disease after surgery: Changes in post‐operative management strategies over time and their impact on long‐term re‐operation rate—A retrospective multicentre real‐world study

Alimentary pharmacology & therapeutics, 2024-06, Vol.59 (12), p.1579-1588

2024

Volltextzugriff (PDF)

Use of biologics for the management of Crohn's disease: IG-IBD technical review based on the GRADE methodology

Digestive and liver disease, 2023-06, Vol.55 (6), p.695-703

2023

Volltextzugriff (PDF)

Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD technical review based on the GRADE methodology

Digestive and liver disease, 2022-04, Vol.54 (4), p.428-439

2022

Volltextzugriff (PDF)

Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concerns

Digestive and liver disease, 2020-11, Vol.52 (11), p.1246-1247

2020

Volltextzugriff (PDF)

1 – 25 von 224

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(210)
Mit Volltextzugriff
(192)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Crucial steps in the natural history of inflammatory bowel disease

Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease

SAPHO Syndrome in Crohn’s Disease Successfully Treated with Ustekinumab: Case Report and Review of the Literature

Comparative Effectiveness Research: A Roadmap to Sail the Seas of IBD Therapies

Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease

Stricturing Crohn's disease: what is the role of endoscopic stenting? A systematic review

Should the Mediterranean diet be recommended for inflammatory bowel diseases patients? A narrative review

Mucosal healing in inflammatory bowel disease: Treatment efficacy and predictive factors

Effectiveness of ustekinumab in patients with refractory Crohn’s disease: a multicentre real-life study in Italy

Adalimumab in active ulcerative colitis: A “real-life” observational study

Timing of Cholecystectomy for Acute Calculous Cholecystitis: A Meta-Analysis

Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD “AGED study”

Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus

Incident Colorectal Cancer in Inflammatory Bowel Disease

Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study

Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life Study

Intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant Sars-CoV-2 infection

Randomized controlled trials in prevention of postsurgical recurrence in Crohn's disease

Author's Reply: ``Use of biologics for the management of Crohn's disease'

Mucosal healing as a treatment for IBD?

No impact of restructuring IBD-related activity during COVID-19 outbreak on patient outcomes. A single Center experience

Crohn's disease after surgery: Changes in post‐operative management strategies over time and their impact on long‐term re‐operation rate—A retrospective multicentre real‐world study

Use of biologics for the management of Crohn's disease: IG-IBD technical review based on the GRADE methodology

Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD technical review based on the GRADE methodology

Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concerns

Suchergebnisse filtern